Abstract:Abstract The decline in early life mortality since the 1950s has resulted in dramatic demographic shift towards aged population. Aging manifests as a decline in health, multiple organ dysfunction and increased vulnerability to diseases, which degrades quality of life. A verity of genetic and pharmacological interventions, mostly from non-vertebrate models, have been identified that can enhance lifespan. Whether these interventions extend healthspan, the disease free and functional period of life, has only sometimes been tested and is often a matter of debate. Human aging indices have been developed to assess elements of functional decline with aging (e.g. sarcopenia, cognitive function). However, corresponding comprehensive indices in mice are seldom applied to aging studies. To probe the relationship between healthspan and lifespan extension in mammals, we performed a series of longitudinal, clinically-relevant healthspan measurements. Metabolism and aging are tightly connected and specific perturbations of nutrient-sensing pathways can enhance longevity in laboratory animals. Here we show that alpha-ketoglutarate (delivered in the form of a Calcium salt, CaAKG), a key metabolite in tricarboxylic (TCA) cycle that is reported to extend lifespan in worms, can significantly extend lifespan and healthspan in mice. AKG is involved in various fundamental processes including collagen synthesis and epigenetic changes. Due to its broad roles in multiple biological processes, AKG has been a subject of interest for researchers in various fields. AKG also influences several age-related processes, including stem cell proliferation and osteoporosis. To determine its role in mammalian aging, we administered CaAKG in 18 months old mice and determined its effect on the onset of frailty and survival, discovering that the metabolite promotes longer, healthier life associated with a decrease in levels of inflammatory factors. Interestingly the reduction in frailty was more dramatic than the increase in lifespan, leading us to propose that CaAKG compresses morbidity.

Unveiling ceramide dynamics: Shedding light on healthy aging in growth hormone‐releasing hormone knockout mice

Growth hormone‐releasing hormone deficiency confers extended lifespan and metabolic resilience during high‐fat feeding in mid and late life

Insulin sensitivity in long-lived growth hormone-releasing hormone knockout mice

Coordinated transcriptional upregulation of oxidative metabolism proteins in long-lived endocrine mutant mice

Muscle-dependent regulation of adipose tissue function in long-lived growth hormone-mutant mice

Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan

Transcriptome profiling reveals divergent expression shifts in brown and white adipose tissue from long-lived GHRKO mice

Roles of Growth Hormone-Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence

Isolating the Direct Effects of Growth Hormone on Lifespan and Metabolism

Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice

Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers

Reduced Expression of C/EBPβ-LIP Extends Health- and Lifespan in Mice

Genetic Disruption of KLF1 K74 SUMOylation in Hematopoietic System Promotes Healthy Longevity in Mice

The Effects of Age and Reproduction on the Lipidome of Caenorhabditis elegans

Proteomics of Long‐Lived Mammals

A lipidome landscape of aging in mice

Lysosomal Signaling Molecules Regulate Longevity in Caenorhabditis Elegans

Growth Hormone and Aging: New Findings

Improved resilience and proteostasis mediate longevity upon DAF-2 degradation in old age

Caloric restriction reveals a metabolomic and lipidomic signature in liver of male mice